相关实验视频

Updated: Jun 20, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

免疫治疗固体瘤的动态毒性景观跨治疗线的治疗线

Lihui Liu^1,2, Sini Li^1,2, Guoqiang Wang³

¹Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Journal of the National Cancer Center

|July 22, 2024

概括

免疫检查点抑制剂 (ICI) 在以后的治疗线路中显示出降低的毒性. 这项研究分析了155个队列,发现随着治疗的进展,不管ICI组合,不良事件越来越少.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
临床药理学临床药理学

背景情况:

针对PD-1/PD-L1,CTLA-4和LAG-3的免疫检查点抑制剂 (ICI) 在癌症治疗中至关重要.
了解不同治疗线的ICI相关毒性对于优化患者护理至关重要.

研究的目的:

为了全面描述免疫检查点抑制剂 (ICI) 毒性.
为了阐明ICI毒性模式在癌症治疗的各个方面.

主要方法:

一个对155个队列 (24,539名患者) 的元分析,检查ICI安全数据.
数据提取包括试验细节,患者人口统计和与治疗相关的不良事件 (trAEs).
基于时间线的方法和对不良事件率 (SPAER) 的合成原理被用来比较跨治疗线的毒性.

主要成果:

随着ICI治疗的后续线路,观察到与治疗相关的不良事件 (trAEs) 的显着减少.
在单疗法和组合ICI疗法中,TRAE的发生率与治疗线呈负相关性.
敏感性分析证实了这些发现,强调了随着治疗进展的毒性下降的趋势.

结论:

免疫检查点抑制剂 (ICI) 毒性在治疗线上表现出一种动态模式.
在晚期治疗中接受ICI的患者可能会经历较低的治疗相关不良事件 (trAEs) 风险.
这表明,通过先进阶段的ICI治疗,有可能提高安全性.

关键词:

免疫治疗是一种免疫疗法.固体瘤是一种固体瘤.有毒性有毒性处理线路的处理线.

更多相关视频

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...